(Q72584434)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7873129%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7873129%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

author name string

A Fredriksson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7873129%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

C Gentsch

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7873129%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

T Archer

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7873129%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7873129%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7873129%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7873129%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

197-209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7873129%20AND%20SRC:MED&resulttype=core&format=json

A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice

27 October 2019

cites work

1 reference

12 December 2020

Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia

1 reference

12 December 2020

MPTP-induced hypoactivity in mice: reversal by L-dopa.

1 reference

12 December 2020

The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors

1 reference

12 December 2020

Behavioural pharmacology of glutamate in the basal ganglia

1 reference

12 December 2020

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

1 reference

12 December 2020

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

1 reference

12 December 2020

Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression

1 reference

12 December 2020

Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks

1 reference

12 December 2020

Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801

1 reference

12 December 2020

The NMDA antagonist dizocilpine (MK-801) reverses haloperidol-induced movement initiation deficits.

1 reference

12 December 2020

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

12 December 2020

The competitive NMDA antagonist CGP40.116 enhances L-dopa response in MPTP-treated marmosets

1 reference

12 December 2020

Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice

1 reference

12 December 2020

MK-801-induced stereotypy and its antagonism by neuroleptic drugs

1 reference

12 December 2020

Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice

1 reference

12 December 2020

Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate

1 reference

12 December 2020

Dopamine agonists potentiate antiakinetic effects of competitive NMDA-antagonists in monoamine-depleted mice

1 reference

12 December 2020

Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats.

1 reference

12 December 2020

Drug therapy of Parkinson's disease. An overview

1 reference

12 December 2020

MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys

1 reference

12 December 2020

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

1 reference

12 December 2020

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

1 reference

12 December 2020

The topography of MK-801-induced locomotor patterns in rats

1 reference

12 December 2020

The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats.

1 reference

12 December 2020

Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease.

1 reference

12 December 2020

Anticataleptic potencies of glutamate-antagonists

1 reference

12 December 2020

NMDA receptor antagonists inhibit ethanol-produced locomotor stimulation in NMRI mice

1 reference

12 December 2020

CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity

1 reference

12 December 2020

Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat.

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

1 reference

12 December 2020

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

12 December 2020

Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists

1 reference

12 December 2020

The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents

1 reference

12 December 2020

Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: an in vivo magnetic resonance imaging study.

1 reference

12 December 2020

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

12 December 2020

Functions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug actions

1 reference

12 December 2020

Regional alterations in brain amino acids after administration of the receptor antagonists MK-801 and CGP 39551 in rats

1 reference

12 December 2020

Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals

1 reference

12 December 2020

Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat.

1 reference

12 December 2020

The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior

1 reference

12 December 2020

Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats

1 reference

12 December 2020

3HMK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02336141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7873129%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference